Medical devices, healthcare technology and the business of care
510(k) clearance · K262424

Willow 12 Guidewire

Arbor Endovascular, LLC · Decision date Aug 14, 2026

FDA DECISIONK262424

What did the FDA decide?

FDA records K262424 as a 510(k) premarket notification, with a decision dated Aug 14, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Aug 14, 2026

FDA source record

Regulatory record facts

Identifier
K262424
Regulatory pathway
510(k) premarket notification
Product code
MOF
Decision code
SESE
Decision date
Aug 14, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Guide, Wire, Catheter, Neurovasculature.

Product code
MOF
FDA device class
2

FDA decision timeline

  1. K262424 received

    Application receipt date recorded by FDA.

  2. K262424 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code MOF

Product / regulatory recordCompanyPathwayDecision dateSource
Scientia Vascular510(k) clearanceSep 16, 2026FDA
Piraeus Medical, Inc.510(k) clearanceAug 27, 2026FDA
Scientia Vascular, Inc.510(k) clearanceAug 6, 2026FDA
Rapid-Medical , Ltd.510(k) clearanceJul 17, 2026FDA
Scientia Vascular, Inc.510(k) clearanceApr 29, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Arbor Endovascular, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
San Jose, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records